Skip to main content

#154240

Anti-CD81 [1s112]

Cat. #154240

Anti-CD81 [1s112]

Cat. #: 154240

Unit size: 100 ug

Availability: 10-12 weeks

Target: CD81 and its second extracellular domain (EC2)

Class: Monoclonal

Application: WB ; ELISA ; FACS ; IF

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: University of Birmingham

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CD81 [1s112]
  • Alternate name: 26 kDa cell surface protein TAPA-1,Target of the antiproliferative antibody 1, Tetraspanin-28
  • Research fields: Immunology;Microbiology
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: WB ; ELISA ; FACS ; IF
  • Description: CD81 is co-opted during the life cycle of diversehuman pathogens: it is involved in hepatitis C virus (HCV) andPlasmodium sporozoite invasion of hepatocytes, and alsocontributes to the assembly and budding of human immunodeficiencyvirus and influenza A virus. Developed as a part of panel of murine monoclonalantibodies against full-length CD81 to further examine and assessed their ability to inhibit or neutralize HCV infection.
  • Immunogen: P60033, CD81_HUMAN
  • Immunogen uniprot id: P60033, CD81_HUMAN
  • Myeloma used: NS0

Target Details

  • Target: CD81 and its second extracellular domain (EC2)
  • Target background: CD81 is co-opted during the life cycle of diversehuman pathogens: it is involved in hepatitis C virus (HCV) andPlasmodium sporozoite invasion of hepatocytes, and alsocontributes to the assembly and budding of human immunodeficiencyvirus and influenza A virus. Developed as a part of panel of murine monoclonalantibodies against full-length CD81 to further examine and assessed their ability to inhibit or neutralize HCV infection.

Applications

  • Application: WB ; ELISA ; FACS ; IF

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Tkachuk et al. 1975. FEBS Lett. 52(1):66-8. PMID: 1123084.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.